Evidence map›Paper›PMID 39872219›Full record

ArticleJournal of clinical and experimental hepatology

Liver Organoids From Hepatocytes of Healthy Humans and Non-alcoholic Fatty Liver Disease (NAFLD) Patients Display Multilineage Architecture and can be Used to Develop an

Yamini Goswami, Akash Baghel, Ghanshyam Sharma, Phulwanti K Sharma, Sagnik Biswas, Rajni Yadav, Pramod K Garg, Shalimar, Ruchi Tandon

Abstract read
In one paragraph

Article in Journal of clinical and experimental hepatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yamini GoswamiBRIC-Translational Health Science and Technology Institute, Faridabad, Haryana, India.
Akash BaghelBRIC-Translational Health Science and Technology Institute, Faridabad, Haryana, India.
Ghanshyam SharmaBRIC-Regional Centre for Biotechnology, Faridabad, Haryana, India.
Phulwanti K SharmaBRIC-Translational Health Science and Technology Institute, Faridabad, Haryana, India.
Sagnik BiswasAll India Institute of Medical Sciences, New Delhi, India.
Rajni YadavAll India Institute of Medical Sciences, New Delhi, India.
Pramod K GargBRIC-Translational Health Science and Technology Institute, Faridabad, Haryana, India.
ShalimarAll India Institute of Medical Sciences, New Delhi, India.
Ruchi TandonBRIC-Translational Health Science and Technology Institute, Faridabad, Haryana, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aim: Non-alcoholic fatty liver disease (NAFLD) is a global health concern with limited treatment options. The paucity of predictive Methods: An Results: HLOs and HLO Conclusion: The

Indexed as

InVitro screeningliver organoidsnon-alcoholic fatty liver disease (NAFLD)primary human hepatocytessteatohepatitis

Identifiers

PMID39872219
PMCPMC11761825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.